Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits antihypertensive activity by promoting sodium and urine excretion. It inhibits the release of adrenocorticotropic hormone (ACTH) and beta-endorphin by suppressing pro-opiomelanocortin (POMC) expression. Additionally, it elevates cGMP levels in RMIC cells, with an IC50 of 1.2 nM.
Formula:
C127H205N45O39S3.xC2HF3O2
Target:
Endogenous Metabolite
TP3116
* VAT and and shipping costs not included. Errors and price changes excepted